NEWSROOM

PBIO

Pressure BioSciences’ Revolutionary UST Platform Featured in Leading North American Cannabis Magazine

Aug 7, 2020

Cannabis Brightline Article Highlights Potential of PBI's UST Platform to Play Significant Role in Multiple Billion Dollar Markets - Including CBD, Cosmetics, Nutraceuticals, Biopharmaceuticals, and Food/Beverage South Easton, Massachusetts--(Newsfile Corp. - January 17, 2020) - Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

read more

Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update

Aug 7, 2020

Conference Call Scheduled for Thursday, December 19th at 4:30 pm ET   South Easton, MA, December 18, 2019 -- – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2019 financial results and to provide a business update (including a discussion of progress made in its development of instrumentation for the nanoemulsification of oil and water, including CBD Oil). Anyone interested may listen to...

read more

Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.

Aug 7, 2020

  South Easton, MA, October 4, 2019 -- – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has initiated coverage on the Company. Copies of the new Zacks SCR report can be obtained via the following link: PBIO: Groundwork laid; opportunities...

read more

Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting

Aug 7, 2020

  Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow  Could Lead to Improvement in the Clinical Management of Gynecological Cancers South Easton, MA, October 1, 2019  -- – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »